RecruitingNCT06729541
Genetically guided medication choices for depression, bipolarity and psychosis
About this title
Read the official source — NCT06729541Interventional studyAges 18–65China
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- BeijingSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 11, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 600
- Sponsor
- Peking University
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other
- Locations
- China
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06729541
- Official title
Show the full official title
Development and Application of Precision Treatment Strategies for Patients with Depression, Bipolar Disorder, and Schizophrenia: a Multicenter Randomized Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Beijing
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Peking University, a university.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
